ZYBT - Zhengye Biotechnology Holding Limited Ordinary Shares

ZYBT - Zhengye Biotechnology Holding Limited Ordinary Shares

https://www.jlzybio.com

Recent News

Powered by Alpha Vantage

Zhengye Biotechnology Stock Is Trading Lower On Monday: What's Going On? - Zhengye Biotechnology ( NASDAQ:ZYBT )

Benzinga • 2 months, 3 weeks ago • score: 0.15

Zhengye receives a Nasdaq notice for failing to file its 2024 annual report on time. The company has 60 days to submit a compliance plan to avoid potential delisting. Get access to the leaderboards pointing to tomorrow's biggest stock movers.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$14.30

52W Low

$3.50

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

Rich

As of 2023-12-31 (Overview)

Trailing P/E (<15 better)

83.17

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

31.36

EV/Revenue (<3 favorable)

9.48

P/S (TTM) (<3 favorable)

1.24

P/B (<3 favorable)

6.11

Ownership

Source: Overview

Insiders (1–5% typical)

91.64%

Institutions (25–75% balanced)

0.00%

Shares Outstanding

47,166,400

Float

4,068,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2023-12-31 (Overview)

Revenue (TTM)

189,748,000

Gross Profit (TTM)

105,327,000

EPS (TTM)

0.06

Profit Margin (>10% good)

0.11%

Operating Margin (TTM) (higher better)

0.16%

ROE (TTM) (>15% strong)

0.07%

EPS YoY (Quarterly) (>10% good)

-0.55

Revenue YoY (Quarterly) (>8% good)

-0.19

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—